Healthcare provider profile · identity verified

Dylan Tracy, D.O.

Family Practice · BURIEN, WA · NPI 1932580263

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	507	155
Amlodipine Besylate	Amlodipine Besylate	299	115
Levothyroxine Sodium	Levothyroxine Sodium	267	92
Losartan Potassium	Losartan Potassium	246	84
Lisinopril	Lisinopril	231	76
Gabapentin	Gabapentin	199	65
Omeprazole	Omeprazole	193	58
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	162	22
Metoprolol Succinate	Metoprolol Succinate	161	57
Tamsulosin Hcl	Tamsulosin Hcl	159	63
Furosemide	Furosemide	142	49
Trazodone Hcl	Trazodone Hcl	136	49
Metformin Hcl	Metformin Hcl	127	47
Tramadol Hcl	Tramadol Hcl	120	19
Simvastatin	Simvastatin	114	39
Sertraline Hcl	Sertraline Hcl	110	40
Zolpidem Tartrate	Zolpidem Tartrate	105	27
Albuterol Sulfate Hfa	Albuterol Sulfate	90	36
Metoprolol Tartrate	Metoprolol Tartrate	79	25
Oxycodone Hcl	Oxycodone Hcl	78	15
Pantoprazole Sodium	Pantoprazole Sodium	73	25
Rosuvastatin Calcium	Rosuvastatin Calcium	73	29
Hydrochlorothiazide	Hydrochlorothiazide	72	30
Meloxicam	Meloxicam	70	24
Potassium Chloride	Potassium Chloride	63	22
Duloxetine Hcl	Duloxetine Hcl	60	12
Fluticasone Propionate	Fluticasone Propionate	59	38
Allopurinol	Allopurinol	55	22
Clopidogrel	Clopidogrel Bisulfate	55	19
Citalopram Hbr	Citalopram Hydrobromide	54	18
Metformin Hcl Er	Metformin Hcl	52	16
Alprazolam	Alprazolam	51	17
Fluoxetine Hcl	Fluoxetine Hcl	50	16
Atenolol	Atenolol	46	16
Tizanidine Hcl	Tizanidine Hcl	44	14
Famotidine	Famotidine	43	15
Lorazepam	Lorazepam	43	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	43	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	42	27
Carvedilol	Carvedilol	41	15
Montelukast Sodium	Montelukast Sodium	39	15
Clonazepam	Clonazepam	37	suppressed
Mirtazapine	Mirtazapine	37	suppressed
Finasteride	Finasteride	36	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	34	21
Jardiance	Empagliflozin	33	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	33	16
Eliquis	Apixaban	31	14
Glipizide	Glipizide	31	13
Xarelto	Rivaroxaban	31	12
Pravastatin Sodium	Pravastatin Sodium	30	11
Ramipril	Ramipril	30	13
Alendronate Sodium	Alendronate Sodium	27	11
Chlorthalidone	Chlorthalidone	27	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	27	14
Hydrocortisone	Hydrocortisone	27	13
Levetiracetam	Levetiracetam	27	suppressed
Ropinirole Hcl	Ropinirole Hcl	27	suppressed
Ezetimibe	Ezetimibe	26	suppressed
Prednisone	Prednisone	26	13
Telmisartan	Telmisartan	26	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	25	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	24	suppressed
Propranolol Hcl Er	Propranolol Hcl	23	suppressed
Spironolactone	Spironolactone	23	13
Benazepril Hcl	Benazepril Hcl	22	suppressed
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Pregabalin	Pregabalin	22	suppressed
Diclofenac Sodium	Diclofenac Sodium	21	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	21	suppressed
Terazosin Hcl	Terazosin Hcl	21	suppressed
Terbinafine Hcl	Terbinafine Hcl	21	suppressed
Glipizide Er	Glipizide	20	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	20	suppressed
Baclofen	Baclofen	19	suppressed
Cephalexin	Cephalexin	19	11
Propranolol Hcl	Propranolol Hcl	19	suppressed
Arnuity Ellipta	Fluticasone Furoate	18	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	18	suppressed
Diazepam	Diazepam	18	suppressed
Latanoprost	Latanoprost	18	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	16
Bupropion Xl	Bupropion Hcl	17	suppressed
Ketoconazole	Ketoconazole	17	suppressed
Lidocaine	Lidocaine	17	suppressed
Ozempic	Semaglutide	17	suppressed
Clobetasol Propionate	Clobetasol Propionate	16	suppressed
Divalproex Sodium	Divalproex Sodium	16	suppressed
Doxepin Hcl	Doxepin Hcl	16	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Lovastatin	Lovastatin	16	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Morphine Sulfate Er	Morphine Sulfate	15	suppressed
Sucralfate	Sucralfate	15	suppressed
Cefdinir	Cefdinir	14	13
Estradiol	Estradiol	14	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Lansoprazole	Lansoprazole	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Synthroid	Levothyroxine Sodium	14	suppressed
Abilify Maintena	Aripiprazole	13	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	13	suppressed
Azithromycin	Azithromycin	13	12
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Prenatal Vitamin Plus Low Iron	Pnv,calcium 72/Iron/Folic Acid	13	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	13	suppressed
Warfarin Sodium	Warfarin Sodium	13	suppressed
Buspirone Hcl	Buspirone Hcl	12	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Lacosamide	Lacosamide	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Colchicine	Colchicine	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Varenicline Tartrate	Varenicline Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error